Cybin Revenue

Revenue (ttm)

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

203.12M USD

Revenue Chart

* This company reports financials in CAD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	-	-	-
Mar 31, 2023	-	-	-
Mar 31, 2022	-	-	-
Mar 31, 2021	864.00K	-	-
Mar 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Procaps Group	414.10M
Inogen	326.65M
Adaptimmune Therapeutics	141.46M
Fulcrum Therapeutics	81.63M
Nanobiotix	45.22M
Caribou Biosciences	33.11M
scPharmaceuticals	24.05M
Orchestra BioMed Holdings	2.08M

Revenue Rankings

CYBN News

5 days ago - Cybin to Participate at the 2024 Milken Institute Future of Health Summit - Business Wire
12 days ago - Cybin Announces Grant of First U.S. Composition of Matter Patent in Support of its CYB005 Phenethylamines Program - Business Wire
18 days ago - Undercovered Dozen: Endava, Cross Country Healthcare, Cybin, Equinor + - Seeking Alpha
21 days ago - Cybin: Top Value Psychedelic Stock - Seeking Alpha
4 weeks ago - Cybin to Participate in Water Tower Research Fireside Chat on October 8, 2024 - Business Wire
5 weeks ago - Cybin Expands Clinical Team to Support CYB003 Phase 3 Program - Business Wire
5 weeks ago - Water Tower Research Publishes Initiation of Coverage Report on Cybin, Inc., “A Leader in Novel Neuropsychiatry Therapeutics” - GlobeNewsWire
6 weeks ago - Cybin to Participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit - Business Wire

More News